August 01, 2014
Authored and Edited by Morgan E. Smith
The TTAB recently clarified its procedures for making evidence of record through notices of reliance. After the close of its testimony period, Applicant sought to reopen the period in order to file an additional notice of reliance. The exhibits attached to this notice of reliance included a “Supplemental Expert Report” and the documents referenced in the report. The Board excluded the Supplemental Expert Report because it was not proper subject matter for introduction via a notice of reliance. The Board then considered the possibility that the report was admissible because the parties had so stipulated. The report was not admissible on this basis because the parties’ stipulations covered the expert’s initial report, but did not address the admissibility of any additional expert reports, affidavits, or declaration testimony. The report also did not qualify as proper supplementation under the Federal Rules of Civil Procedure because, by Applicant’s own admission, it contained additional opinions designed to rebut Opposer’s expert report, rather than correct any inaccuracies in Applicant’s initial report. The documents referenced in the “Supplemental Expert Report” were admissible because they were printed publications and constituted proper subject matter for a notice of reliance. The Board struck the “Supplemental Expert Report” and reminded the Applicant that it could have avoided this problem altogether had it simply taken the expert’s deposition during its testimony period.
Copyright © 2014 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.
At the PTAB Blog
IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026
May 26, 2026
At the PTAB Blog
May 20, 2026
Conference
19th Annual Forum on Pharma & Biotech Patent Litigation in Europe
May 19-20, 2026
Amsterdam
Webinar
Changes at the PTAB from Settled Expectations to Real Parties in Interest to Director Involvement
May 18, 2026
Webinar
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.